共 50 条
- [24] Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis JOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1395 - 1402
- [25] Anti-Transcription Intermediary Factor 1-Gamma (TIF1-γ) Autoantibody ELISA Development and Validation. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S826 - S826
- [27] Flagellate erythema in transcription intermediary factor 1 gamma dermatomyositis RHEUMATOLOGY & AUTOIMMUNITY, 2024, 4 (03): : 194 - 195
- [28] Transcription Intermediary Factor (TIF)-1β Is a New Dermatomyositis Autoantigen ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S84 - S84
- [29] Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis Arthritis Research & Therapy, 14